Future Costs in Cost-Effectiveness Analyses: Past, Present, Future Linda M. de VriesPieter H. M. van BaalWerner B. F. Brouwer Leading Article Open access 26 November 2018 Pages: 119 - 130
Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal Ros WadeAlessandro GrossoStephen Palmer Review Article 16 August 2018 Pages: 131 - 139
Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Nasuh C. BüyükkaramikliSaskia de GrootMaiwenn J. Al Review Article Open access 08 September 2018 Pages: 141 - 153
The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence Richard PerryGeorge BraileanuPaul Stevens Review Article Open access 13 October 2018 Pages: 155 - 167
Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review Edward T. ChiyakaVan T. NghiemPhuc Le Systematic Review 27 October 2018 Pages: 169 - 200
Discrete Choice Experiments in Health Economics: Past, Present and Future Vikas SoekhaiEsther W. de Bekker-GrobCaroline M. Vass Systematic Review Open access 03 November 2018 Pages: 201 - 226
Does a Patient-Directed Financial Incentive Affect Patient Choices About Controller Medicines for Asthma? A Discrete Choice Experiment and Financial Impact Analysis Tracey-Lea LabaHelen K. ReddelStephen Jan Original Research Article 27 October 2018 Pages: 227 - 238
Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States Eytan SteinJipan XieGeorge Joseph Original Research Article 01 November 2018 Pages: 239 - 253
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data Andrea MarcellusiRaffaella VitiPITER Collaborating group available at www.progettopiter.it Original Research Article 30 October 2018 Pages: 255 - 266
Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand Bunchai ChongmelaxmePochamana PhisalprapaNathorn Chaiyakunapruk Original Research Article 15 November 2018 Pages: 267 - 278
Cost-Effectiveness Analysis of Direct-Acting Oral Anticoagulants for Stroke Prevention in Thai Patients with Non-Valvular Atrial Fibrillation and a High Risk of Bleeding Thananan RattanachotphanitChulaporn LimwattananonKittisak Sawanyawisuth Original Research Article 02 November 2018 Pages: 279 - 289
Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand Bunchai ChongmelaxmePochamana PhisalprapaNathorn Chaiyakunapruk Correction 13 December 2018 Pages: 291 - 291
